Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.59
-0.21 (-1.18%)
Mar 10, 2026, 2:23 PM HKT
-45.03%
Market Cap 2.42B
Revenue (ttm) 2.34M
Net Income (ttm) -123.26M
Shares Out 136.22M
EPS (ttm) -11.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 43,700
Average Volume 122,974
Open 18.20
Previous Close 17.80
Day's Range 17.03 - 18.20
52-Week Range 13.48 - 32.00
Beta 0.84
RSI 44.21
Earnings Date n/a

About HKG:3378

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. develops and manufactures immunotherapies for cancer and autoimmune diseases. The company's products include antibody drugs, including monoclonal, bispecific, and antibody drug conjugates for immuno-oncology pathways. The company was incorporated in 2014 and is headquartered in Wuhan, China. [Read more]

Industry Marine Shipping
Sector Industrials
Founded 2014
Employees 55
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3378
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.